Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 150 | 430 | 0 | 0 | 0 |
| Cost of Goods | 35 | 120 | N/A | N/A | N/A |
| Gross Profit | 115 | 310 | N/A | N/A | N/A |
| Operating Expenses | 5,939 | 2,847 | 147 | 166 | 386 |
| Operating Income | -5,789 | -2,417 | -147 | -166 | -386 |
| Other Income | 43 | -4 | 7 | 16 | 57 |
| Pre-tax Income | -5,746 | -2,421 | -141 | -150 | -329 |
| Net Income Continuous | -5,746 | -2,421 | -141 | -150 | -329 |
| Net Income | $-5,746 | $-2,421 | $-141 | $-150 | $-329 |
| EPS Basic Total Ops | -3.10 | -1.30 | -5.00 | -5.00 | -10.00 |
| EPS Basic Continuous Ops | -3.10 | -1.30 | -4.83 | -5.14 | -10.20 |
| EPS Diluted Total Ops | -3.10 | -1.30 | -5.00 | -5.00 | -10.00 |
| EPS Diluted Continuous Ops | -3.10 | -1.30 | -4.83 | -5.14 | -10.19 |
| EBITDA(a) | $-5,478 | $-2,294 | $-147 | $-166 | $-386 |